Sökresultat - "Endometrial carcinoma"
-
1
Clear cell endometrial carcinoma: analysis of the results of a 20-year follow-up
Publicerad 2014-08-01Ämnen: “…endometrial carcinoma…”The paper presents data on the clinical and morphological characteristics, clinical presentation, and treatment of clear cell carcinoma, as well as survival rates in patients with this condition. It shows an association of the expression of the intercellular adhesion molecules E-cadhedrin, α- and β-...
Hämta fulltext
Artikel -
2
Carcinoma of the endometrium: A case report and literature review
Publicerad 2025-07-01 Ämnen: “…Endometrial carcinoma…”
Hämta fulltext
Artikel -
3
GWAS meta-analysis identifies five susceptibility loci for endometrial cancerResearch in context
Publicerad 2025-08-01Ämnen: “…Endometrial carcinoma…”Summary: Background: Endometrial cancer is the most common gynaecological cancer in high-income countries. In addition to environmental risk factors, genetic predisposition contributes towards endometrial cancer development but is still incompletely defined. Methods: Building on genome-wide associa...
Hämta fulltext
Artikel -
4
Multi-omics analysis of the anti-cancer effects of curcumol in endometrial carcinoma
Publicerad 2025-07-01Ämnen: Hämta fulltextBackgroundEndometrial carcinoma (EC) is one of the most common gynecologic malignancies, with increasing global morbidity and mortality rates. Curcumol, a sesquiterpenoid hemicrystalline compound, exhibits notable pharmacological effects, including anticancer, anti-inflammatory, and antiviral proper...
Artikel -
5
Cerebral metastases of endometrial carcinoma. Diagnostic and neurosurgical aspects
Publicerad 2014-07-01Ämnen: “…endometrial carcinoma…”Central nervous system (CNS) involvement by endometrial carcinoma is uncommon. Among 1710 patients registered for brain metastases at our institution between 1990 and 2012, 3 (0.18 %) developed brain metastases. All lesions (1 multiple, 2 single) were contrast enhancing on com- puted tomography scan...
Hämta fulltext
Artikel -
6
The characteristics of the endometrial pathology in premenopausal period
Publicerad 2023-01-01Ämnen: “…highly differentiation endometrial carcinoma…”The goal of study was to study the incidence and the clinical manifestation of the endometrial pathology in premenopausal period. 73 premenopausal women with various endometrial pathology were examined. The average age of the examined was 47.82 ± 0.27 (45-51) years. The age of the menarche was 11.0...
Hämta fulltext
Artikel -
7
The impact of cyclin D1 on endometrial hyperplasia and endometrioid endometrial carcinoma
Publicerad 2025-06-01Ämnen: Hämta fulltextIntroduction: Endometrioid endometrial carcinoma (EEC) is the most common type of endometrial cancer, accounting for approximately 80-90% of all endometrial cancer cases. Endometrial hyperplasia deserves special attention because of its relationship with endometrialcinoma. This study's goal was...
Artikel -
8
Possible applications for combined lenvatinib and pembrolizumab in advanced endometrial carcinoma
Publicerad 2023-01-01Ämnen: “…endometrial carcinoma…”Endometrial cancer is one of the most common gynaecological cancers in both the United States and the Russian Federation, and the rate continues to rise. Although early-stage endometrial cancer is associated with a favourable 5-year survival rate (96%), this rate in patients with distant metastases...
Hämta fulltext
Artikel -
9
Establishment of a nine‐gene prognostic model for predicting overall survival of patients with endometrial carcinoma
Publicerad 2018-06-01Ämnen: “…Endometrial carcinoma…”Abstract Endometrial carcinoma (EC) is the most common malignant tumor of the female genital tract in developed countries. The prognosis of early stage EC is favorable, but a subset faces high risk of cancer progression or recurrence. EC has a poor prognosis upon progression to advanced or metastati...
Hämta fulltext
Artikel -
10
The immune microenvironment in endometrial carcinoma: mechanisms and therapeutic targeting
Publicerad 2025-07-01Ämnen: “…endometrial carcinoma…”Endometrial carcinoma (EC) represents one of the most prevalent malignancies within the female reproductive system. The frequency of its occurrence is on the rise annually, and patients diagnosed at advanced stages face a less favorable prognosis. Recent studies have highlighted the significant infl...
Hämta fulltext
Artikel -
11
Immunogenic cell death-related genes as prognostic biomarkers and therapeutic insights in uterine corpus endometrial carcinoma: an integrative bioinformatics analysis
Publicerad 2025-07-01Ämnen: “…uterine corpus endometrial carcinoma…”IntroductionImmunogenic cell death (ICD) is the phenomenon in which tumor cells undergo the transition from a non-immunogenic state to an immunogenic state upon their demise as a result of external stimuli. While ICD systems have been widely adopted in oncological research, their specific utilizatio...
Hämta fulltext
Artikel -
12
Impact of the microcystic, elongated, and fragmented invasion pattern on prognosis in endometrial carcinoma: a comprehensive meta-analysis
Publicerad 2025-06-01Ämnen: Hämta fulltextThe prognostic significance of the microcystic, elongated, and fragmented (MELF) invasion pattern in endometrial carcinoma (EC) has not been fully elucidated. This study conducted a systematic search across five electronic databases (PubMed, EMBASE, Cochrane, Web of Science, and the Chinese National...
Artikel -
13
Human epidermal growth factor receptor 2 expression and associated factors in endometrial carcinoma
Publicerad 2025-06-01Ämnen: “…endometrial carcinoma…”ObjectiveTo explore the expression of human epidermal growth factor receptor 2 (HER2) and its associations with clinical, pathological, and imaging characteristics in endometrial carcinoma (EC) patients. MethodsA retrospective analysis was conducted on 214 patients with newly diagnosed EC treated at...
Hämta fulltext
Artikel -
14
Cyclin D2 – a potential biomarker in uterine corpus endometrial carcinoma through methylation chip and bioinformatic analysis
Publicerad 2025-07-01Ämnen: “…uterine corpus endometrial carcinoma…”BackgroundThe incidence and mortality of uterine corpus endometrial carcinoma (UCEC) is increasing. Despite advances in diagnosis and treatment, the fundamental molecular mechanisms remain unclear to some extent. In this study, the role and clinical significance of Cyclin D2 (CCND2) in UCEC is discu...
Hämta fulltext
Artikel -
15
Features of some growth factors content in tumors and blood plasma in patients with rare forms of endometrial cancer
Publicerad 2025-06-01Ämnen: Hämta fulltextPurpose of the study. The objective of the present study was to examine the levels of TGFβ1, EGF, and EGFR in the blood and tissue of morphologically distinct endometrial tumors, including uterine serous carcinoma (USC), clear cell endometrial cancer (CCEC), and G3 endometrioid adenocarcinoma (EAC)....
Artikel -
16
Successful anti-PD-1 therapy in metastatic endometrial cancer with microsatellite instability: a case report
Publicerad 2019-07-01Ämnen: Hämta fulltextHigh efficacy of anti-PD-1 therapy has been shown in malignant tumors with mismatch repair deficiency. According to the literature review, mismatch repair deficiency is determined in 20–40 % of all endometrial cancer cases and up to 48 % of its endometrioid subtype. We report the short review of the...
Artikel -
17
COMBINED HORMONOTHERAPY WITH GNRG ANALOGUE AND INTRAUTERINE LEVONORGESTREL-RELEASING SYSTEM OF ATYPICAL ENDOMETRIAL HYPERPLASIA AND WELL-DIFFERENTIATED ENDOMETRIAL CARCINOMA: PROSP...
Publicerad 2012-05-01Ämnen: “…well-differentiated endometrial carcinoma…”The article presents the results of organ-preserving treatment protocol of atypical endometrial hyperplasia and well-differentiated endometrial carcinoma in young women. This protocol was applied in 24 patients. The period of patients observation was 3—6 years. During 6—9 months the patients were gi...
Hämta fulltext
Artikel -
18
Fertility preservation and assisted reproductive strategies in endometrial cancer patients with lynch syndrome
Publicerad 2025-07-01Ämnen: Hämta fulltextPatients with LS-EC can be treated with progestin-based fertility-sparing treatment under close monitoring, and pregnancy is recommended as soon as possible after complete remission (CR) of the disease, with assisted reproduction, supplemented by PGT-M, to minimize the probability of inheritance of...
Artikel